pharmaphorum

JUNE 10, 2021

The need for firms to make a reasonable profit is paramount in today’s world; healthy pharmaceutical research and manufacturing are the keys to ending disease, curing chronic conditions, and discovering new therapies and vaccines that address the latest medical challenges. What’s Next: How Should Pharma Companies Respond? About the author.

Manufacturing 104

Manufacturing Pharma Companies Drugs Pharmacy 104

XTalks

MAY 23, 2024

Drugs such as pembrolizumab (Merck’s Keytruda) and nivolumab (Bristol Myers Squibb’s Opdivo) have revolutionized the treatment options for skin cancer. Ongoing research on molecular diagnostics and AI-powered diagnostic tools has helped enhance the early detection and treatment of skin cancer, promising improved patient outcomes.

Life Science 59

Life Science Dermatology Drug Delivery Systems Medicine 59

Camargo

OCTOBER 14, 2020

The FDA is planning two listening sessions to allow manufacturers, developers, health care providers, researchers, and other interested parties to learn more about the purpose and function of the DHCoE. Approval of the Month: FDA Approves First Closed-Loop Monitoring and Drug Delivery Device. Co-Authors: Ken Phelps.

Development 196

Development Insulin Drug Delivery Production 196

Roots Analysis

MARCH 9, 2022

1] The desired function of excipient in formulation of the medicinal product is to carry the active component to the target site with an active contribution in improving its biological effect, stability, appearance and patient compliance. [2]. Biopharmaceutical Excipient Manufacturing Market.

Manufacturing 52

Manufacturing Marketing Contract Manufacturing Protein 52

The Pharma Data

DECEMBER 14, 2020

Attaining the goals of any given psychedelic-based endeavour will require the removal of federally scheduled enforcement status and global United Nations drug conventions of which the United States and Canada are both participants. About BetterLife Pharma Inc. BetterLife Pharma Inc. About Transcend Biodynamics.

Drug Delivery 40

Drug Delivery Containment Manufacturing Drugs 40

Roots Analysis

SEPTEMBER 13, 2023

Conjugation with a Variety of Molecular Conjugates and Labels The combination of the conjugates / labels with molecules ( proteins, peptides, antibodies and small molecules ) is being used abundantly for several applications, ranging from therapeutics and diagnostics to isolation and characterization of drug delivery systems.

Development 40

Development Antibody Protein Drug Delivery Systems 40

Delveinsight

JANUARY 22, 2021

There are newer agents coming to the market, for instance, Fc receptor via monoclonal IgG antibodies mechanism, BTK [Bruton tyrosine kinase] inhibition, and so on, however, the real challenge lies in the compliance in terms of patients perspectives such as cost and tolerance. appeared first on DelveInsight Business Research.

Marketing 65

Marketing Drugs Antibody Compliance 65

Drug Discovery World

APRIL 3, 2023

DS: What motivated you and Dr David Bunka, CTO, to create Aptamer and did you imagine you would one day be operating on such a global scale?    AT : We initially met at the University of Leeds, where David was a post-doctoral researcher studying aptamers, and I was completing my PhD.

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

The Pharma Data

JANUARY 27, 2021

Utilizing drug delivery platform technologies, BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus.

In-Vitro 52

In-Vitro Containment Drugs Production 52

XTalks

FEBRUARY 24, 2021

For many daily insulin users, the experience is an important one, as it is directly related to quality of life and medication compliance. Through some research, Ward explains they were surprised that even folks that are ‘experienced injectors’ were not faring too well. “We

Insulin 64

Insulin Production Drug Delivery Marketing 64

Delveinsight

NOVEMBER 26, 2020

Non-adherence and non-compliance with the present treatment regimen is another huge hurdle in the road. Consequently, the growth of the RVO drug market is driven by the deep penetration of the emerging pipeline therapies , the rising geriatric population, and an increase in disease awareness.

FDA Approval 63

FDA Approval Marketing Drug Delivery Systems Drugs 63

The Pharma Data

JANUARY 3, 2021

The Company’s pipeline leverages its proprietary bioerodible Durasert® technology for extended intraocular drug delivery including EYP-1901, a potential six-month sustained delivery intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration.

Production 52

Production Sales Development Licensing 52